| Dr J Cameron Kesler, DO | |
|
170 N 1100 E, American Fork, UT 84003-2096 | |
| (801) 855-3267 | |
| Not Available |
| Full Name | Dr J Cameron Kesler |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 18 Years |
| Location | 170 N 1100 E, American Fork, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225189020 | NPI | - | NPPES |
| 39679748 | Medicaid | CO |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Sweetwater County | Rock springs, WY | Hospital |
| American Fork Hospital | American fork, UT | Hospital |
| Lakeview Hospital | Bountiful, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
| Utah Regional Hospitalists Llc | 4789807165 | 145 |
| Memorial Hospital Of Sweetwater County | 0244124550 | 49 |
News Archive
In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.
When loud snoring is interrupted by frequent episodes of obstructed breathing, it is known as obstructive sleep apnea (OSA). As many as 12 million people in the U.S. suffer from this condition, which can require surgical intervention when lifestyle changes and other treatment options fail.
The following is a statement from James A. Goodyear, MD, president of the Pennsylvania Medical Society, regarding a Commonwealth Court 4-1 ruling indicating the state should not have diverted money from the Mcare Fund and Health Care Provider Retention Account to help with state budget problems.
Boston Scientific Corporation today announced results from a pooled patient-level analysis of its PERSEUS and TAXUS ATLAS clinical trial data, demonstrating differences in safety and efficacy outcomes favoring the next-generation ION Platinum Chromium Paclitaxel-Eluting Stent System compared to the currently available TAXUS Liberte Paclitaxel-Eluting Stent System.
Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.
When loud snoring is interrupted by frequent episodes of obstructed breathing, it is known as obstructive sleep apnea (OSA). As many as 12 million people in the U.S. suffer from this condition, which can require surgical intervention when lifestyle changes and other treatment options fail.
The following is a statement from James A. Goodyear, MD, president of the Pennsylvania Medical Society, regarding a Commonwealth Court 4-1 ruling indicating the state should not have diverted money from the Mcare Fund and Health Care Provider Retention Account to help with state budget problems.
Boston Scientific Corporation today announced results from a pooled patient-level analysis of its PERSEUS and TAXUS ATLAS clinical trial data, demonstrating differences in safety and efficacy outcomes favoring the next-generation ION Platinum Chromium Paclitaxel-Eluting Stent System compared to the currently available TAXUS Liberte Paclitaxel-Eluting Stent System.
Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.
› Verified 8 days ago
| Entity Name | Ashley Valley Physician Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740482025 PECOS PAC ID: 4284683947 Enrollment ID: O20050119001166 |
News Archive
In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.
When loud snoring is interrupted by frequent episodes of obstructed breathing, it is known as obstructive sleep apnea (OSA). As many as 12 million people in the U.S. suffer from this condition, which can require surgical intervention when lifestyle changes and other treatment options fail.
The following is a statement from James A. Goodyear, MD, president of the Pennsylvania Medical Society, regarding a Commonwealth Court 4-1 ruling indicating the state should not have diverted money from the Mcare Fund and Health Care Provider Retention Account to help with state budget problems.
Boston Scientific Corporation today announced results from a pooled patient-level analysis of its PERSEUS and TAXUS ATLAS clinical trial data, demonstrating differences in safety and efficacy outcomes favoring the next-generation ION Platinum Chromium Paclitaxel-Eluting Stent System compared to the currently available TAXUS Liberte Paclitaxel-Eluting Stent System.
Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.
When loud snoring is interrupted by frequent episodes of obstructed breathing, it is known as obstructive sleep apnea (OSA). As many as 12 million people in the U.S. suffer from this condition, which can require surgical intervention when lifestyle changes and other treatment options fail.
The following is a statement from James A. Goodyear, MD, president of the Pennsylvania Medical Society, regarding a Commonwealth Court 4-1 ruling indicating the state should not have diverted money from the Mcare Fund and Health Care Provider Retention Account to help with state budget problems.
Boston Scientific Corporation today announced results from a pooled patient-level analysis of its PERSEUS and TAXUS ATLAS clinical trial data, demonstrating differences in safety and efficacy outcomes favoring the next-generation ION Platinum Chromium Paclitaxel-Eluting Stent System compared to the currently available TAXUS Liberte Paclitaxel-Eluting Stent System.
Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.
› Verified 8 days ago
| Entity Name | Utah Regional Hospitalists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962821223 PECOS PAC ID: 4789807165 Enrollment ID: O20140604000236 |
News Archive
In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.
When loud snoring is interrupted by frequent episodes of obstructed breathing, it is known as obstructive sleep apnea (OSA). As many as 12 million people in the U.S. suffer from this condition, which can require surgical intervention when lifestyle changes and other treatment options fail.
The following is a statement from James A. Goodyear, MD, president of the Pennsylvania Medical Society, regarding a Commonwealth Court 4-1 ruling indicating the state should not have diverted money from the Mcare Fund and Health Care Provider Retention Account to help with state budget problems.
Boston Scientific Corporation today announced results from a pooled patient-level analysis of its PERSEUS and TAXUS ATLAS clinical trial data, demonstrating differences in safety and efficacy outcomes favoring the next-generation ION Platinum Chromium Paclitaxel-Eluting Stent System compared to the currently available TAXUS Liberte Paclitaxel-Eluting Stent System.
Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr J Cameron Kesler, DO 7259 S Bingham Junction Blvd, Midvale, UT 84047-4860 Ph: (801) 930-3110 | Dr J Cameron Kesler, DO 170 N 1100 E, American Fork, UT 84003-2096 Ph: (801) 855-3267 |
News Archive
In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.
When loud snoring is interrupted by frequent episodes of obstructed breathing, it is known as obstructive sleep apnea (OSA). As many as 12 million people in the U.S. suffer from this condition, which can require surgical intervention when lifestyle changes and other treatment options fail.
The following is a statement from James A. Goodyear, MD, president of the Pennsylvania Medical Society, regarding a Commonwealth Court 4-1 ruling indicating the state should not have diverted money from the Mcare Fund and Health Care Provider Retention Account to help with state budget problems.
Boston Scientific Corporation today announced results from a pooled patient-level analysis of its PERSEUS and TAXUS ATLAS clinical trial data, demonstrating differences in safety and efficacy outcomes favoring the next-generation ION Platinum Chromium Paclitaxel-Eluting Stent System compared to the currently available TAXUS Liberte Paclitaxel-Eluting Stent System.
Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.
› Verified 8 days ago
Brian J Larson, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-357-8310 | |
Marlan L Hansen, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1159 E 200 N, Suite 150, American Fork, UT 84003 Phone: 801-855-2900 | |
Nicholas Holdaway Bishop, MD, PHD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-357-8310 |